Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AS”

27,115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27,115 results

Post-approval studies (Phase 4)Study completedNCT02021123
What this trial is testing

Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)

Who this might be right for
Obesity Morbid
Radboud University Medical Center 8
Not applicableWithdrawnNCT03892382
What this trial is testing

Repetitive Transcranial Magnetic Stimulation as Therapy for Apathy in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Jagiellonian University
Early research (Phase 1)Study completedNCT03934359
What this trial is testing

Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai De Novo Pharmatech Co., Ltd. 19
Not applicableLooking for participantsNCT06549179
What this trial is testing

Validation Study of the Performance of the French Version of the Autism Mental Status Examination Scale as a Tool for Identifying Autism Spectrum Disorder in Adults

Who this might be right for
Autism Spectrum Disorder
Assistance Publique - Hôpitaux de Paris 410
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Post-approval studies (Phase 4)Not Yet RecruitingNCT07813988
What this trial is testing

Comparing Three Epidural Steroid Injection Approaches for Lumbar Radicular Pain

Who this might be right for
Lumbar Disc HerniationLumbosacral Radiculopathy
Benha University 99
Early research (Phase 1)Study completedNCT06092788
What this trial is testing

Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose

Who this might be right for
Healthy
ATXA Therapeutics Limited 13
Early research (Phase 1)Study completedNCT00783003
What this trial is testing

Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT07269327
What this trial is testing

An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin

Who this might be right for
Fertility
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 24
Early research (Phase 1)Active Not RecruitingNCT05739942
What this trial is testing

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

Who this might be right for
Newly Diagnosed and Recurrent Glioblastoma
Novartis Pharmaceuticals 42
Not applicableStudy completedNCT03531086
What this trial is testing

Idiopathic Parkinson's Progression and Dopamine Transporter SPECT

Who this might be right for
Parkinson Disease
Julie Gurwell 12
Not applicableLooking for participantsNCT06023186
What this trial is testing

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
Michael Ayers 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07739186
What this trial is testing

A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 120
Post-approval studies (Phase 4)UnknownNCT00727870
What this trial is testing

Evaluation of Preferences of Consumers and Clinicians for the Management of Shave Biopsy Sites With a PolyMem Formulation Dressing or Current Standard of Care.

Who this might be right for
Healing
Ferris Mfg. Corp. 90
Large-scale testing (Phase 3)Study completedNCT03399370
What this trial is testing

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol

Who this might be right for
ASCVDElevated Cholesterol
The Medicines Company 1,561
Not applicableStudy completedNCT04922970
What this trial is testing

Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT.

Who this might be right for
Stem Cell TransplantLate EffectMetabolic Syndrome+1 more
Rigshospitalet, Denmark 28
Not applicableUnknownNCT04011969
What this trial is testing

The Role of Gut Microbiome and Chronic Inflammation in Young-onset Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fakultas Kedokteran Universitas Indonesia 150
Post-approval studies (Phase 4)UnknownNCT02557269
What this trial is testing

4"S" - Seasonal Symptoms Suppression Study

Who this might be right for
Seasonal Allergic Rhinitis
Association Asthma, Bulgaria 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03528694
What this trial is testing

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
AstraZeneca 1,018
Testing effectiveness (Phase 2)Study completedNCT05630066
What this trial is testing

Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.

Who this might be right for
Angelman Syndrome
Hoffmann-La Roche 48
Next Page